Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT01380808
Brief Summary:
The progression free survival could be prolonged adding pseudomonas aeruginosa to monotherapy capecitabine.
Detailed Description:
the efficacy of the combination is much better than monotherapy
Study:
NCT01380808
Study Brief:
Protocol Section:
NCT01380808